Current practices, organizational structures, technologies and challenges in developing atmps: A survey by dare-NL, nxtgen hightech, T2EVOLVE and ctiwp of EBMT - a gocart-coalition initiative

Introduction The path from academic development of Advanced Therapy Medicinal Products (ATMPs) to marketing authorization remains complex, with challenges across upscaling, manufacturing, regulatory approval, and clinical integration. Europe continues to lag behind the U.S. and China in the number a...

Full description

Saved in:
Bibliographic Details
Published in:Blood 2025-11, Vol.146, p.5961-5961
Main Authors: Deshantri, Anil, Punt, Simone, Ramesh, Ganesh, Ballardini, Aiko, Martinez Sanchez, Emma, Fernandez-Sojo, Jesus, Querol Giner, Sergi, Sebestyen, Zsolt, Sanges, Carmen, Hudecek, Michael, Das, Ruud, Malard, Florent, Hoogenboom, Jorinde, Mooyaart, Jarl, Ruggeri, Annalisa, Straetemans, Trudy, Kuball, Jurgen
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!